| Net Cash Provided by (Used in) Operating Activities |
$271,196 |
USD |
-3384% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$1,930,333 |
USD |
24795% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$1,511,044 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
409,444,338 |
shares |
61% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$148,093 |
USD |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$148,102 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$1,571,016 |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
$642,120 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |